SNSE Sensei Biotherapeutics, Inc.

NEUTRAL Impact: 2/10 8-K
Horizon immediate Filed May 22, 2026 Processed 23d 12h ago SEC 0001193125-26-236820
8-K context-dependent: Items 8.01
Latest settled — T+5d ⚠ clustered
SNSE ▲ +20.16% at T+5d
NEUTRAL call ✓ call won +20.16% · α vs SPY +19.07% · entry $16.47 → $19.79
Next anchor: T+20d in 8d
Last close $13.00 (close Jun 12) · -21.07% from $16.47 entry
Entry anchored
May 22, 03:58 PM ET
via Databento tick
T+1d
-3.83%
call -3.83% · α -3.78%
$15.84
settled 20d ago
T+5d
+20.16%
call +20.16% · α +19.07%
$19.79
settled 14d ago
T+20d
call — · α —
in 8d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Sensei Biotherapeutics filed an 8-K disclosing that director nominee Karen Vousden requested a delay in her board appointment to later in 2026 due to personal reasons. The company also intends to appoint Bob Holmen as chair of the Nominating and Corporate Governance Committee and set the board size at five directors, contingent on stockholder approval at the upcoming annual meeting. This is a routine governance update with no financial or operational impact.

Actionable Insight

No immediate trading action needed. The filing is a routine governance update with no material effect on operations or financials. Monitor the outcome of the annual meeting for any unexpected changes.

Key Facts

  • Director nominee Karen Vousden requested to delay her board appointment until Q3 or Q4 2026 for personal reasons.
  • Pending stockholder approval, Bob Holmen will be appointed chair of the Nominating and Corporate Governance Committee effective June 12, 2026.
  • The board size has been set at five directors effective June 12, 2026.
  • Annual meeting of stockholders is scheduled for June 10, 2026.

Financial Impact

No financial impact.

Risk Factors

  • Stockholder may not approve the required matters, potentially altering board composition.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
75% bullish (8 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-236820
Document: 0001193125-26-236820-index-headers.html0001193125-26-236820
Document: 0001193125-26-236820-index.html0001193125-26-236820
Document: 0001193125-26-236820.txt0001193125-26-236820
12 reports for SNSE
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +42.80%Apr 28, 2026
Filters
Rows
Reports for SNSE — sortable, filterable
Type Now
Jun 10, 2026
4d ago
S-3/A
NEUTRAL ★ 4/10
$11.26 awaiting T+1awaiting T+1$13.00 (+15.45%)
Jun 10, 2026
4d ago
8-K
NEUTRAL ★ 3/10
$11.26 awaiting T+1awaiting T+1$13.00 (+15.45%)
Jun 2, 2026
12d ago
10-K/A
NEUTRAL ★ 3/10
$16.10 $15.85▼ −1.55%▼ −0.86%$13.00 (−19.23%)
Jun 2, 2026
12d ago
S-3/A
BEARISH ★ 6/10
$16.10 $15.85▲ +1.55%▲ +0.86%$13.00 (+19.23%)
Jun 1, 2026
13d ago
Insider Cluster
BEARISH ★ 7/10
$16.10 $15.85▲ +1.55%▲ +0.83%$13.00 (+19.23%)
May 22, 2026
23d ago
DEFA14A
NEUTRAL ★ 3/10
$16.47 $15.84▼ −3.83%▼ −3.78%$13.00 (−21.07%)
May 22, 2026
23d ago
8-K
NEUTRAL ★ 2/10
$16.47 $15.84▼ −3.83%▼ −3.78%$13.00 (−21.07%)
May 21, 2026
24d ago
DEFA14A
NEUTRAL ★ 5/10
$17.79 $16.47▼ −7.42%▼ −8.01%$13.00 (−26.93%)
May 15, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$20.43 $19.91▼ −2.55%▼ −2.48%$13.00 (−36.37%)
Apr 29, 2026
6w ago
144
BEARISH ★ 5/10
$28.30 $26.62▲ +5.94%▲ +6.96%$13.00 (+54.06%)
Showing 10 of 12

US Market Status

Market Closed — Opens in 4h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access